Stock Update (NYSE:PFE): Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA (BeneFIX®) Once-Weekly Prophylaxis For Hemophilia B

[at noodls] – Once-Weekly Prophylaxis Treatment with BeneFIX® Significantly Reduced Annualized Bleeding Rate Compared to On-Demand Treatment “Pfizer remains committed to the research and development of new and … Read more on this. . . . → Read More: Stock Update (NYSE:PFE): Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA (BeneFIX®) Once-Weekly Prophylaxis For Hemophilia B Similar Articles: Market Update: Pfizer Inc (NYSE:PFE) – Pfizer Announces Submission of Biologics License Application to the FDA for Investigational Meningococcal B Vaccine Market Update: Pfizer Inc (NYSE:PFE) – AstraZeneca rejects Pfizer’s raised bid of $106 bln Market Update (NYSE:PFE): Pfizer prepares sweeter bid for AstraZeneca – report